Stem (NYSE:STEM) Price Target Lowered to $0.60 at UBS Group

Stem (NYSE:STEMFree Report) had its price target decreased by UBS Group from $1.00 to $0.60 in a research report report published on Friday,Benzinga reports. UBS Group currently has a buy rating on the stock.

Other research analysts also recently issued research reports about the company. Evercore ISI decreased their price objective on Stem from $9.00 to $5.00 and set an “outperform” rating on the stock in a report on Wednesday, August 7th. TD Cowen downgraded shares of Stem from a “buy” rating to a “hold” rating and dropped their target price for the stock from $4.00 to $1.00 in a research note on Wednesday, August 7th. Susquehanna raised their target price on shares of Stem from $0.50 to $0.60 and gave the stock a “neutral” rating in a report on Wednesday, October 16th. The Goldman Sachs Group lowered their price target on shares of Stem from $0.75 to $0.65 and set a “neutral” rating on the stock in a research report on Friday, November 1st. Finally, Barclays lowered their price target on shares of Stem from $4.00 to $1.00 and set an “equal weight” rating for the company in a report on Friday, October 18th. Seven equities research analysts have rated the stock with a hold rating and two have given a buy rating to the stock. Based on data from MarketBeat.com, Stem has a consensus rating of “Hold” and a consensus target price of $1.86.

Get Our Latest Stock Report on STEM

Stem Stock Up 3.4 %

Shares of Stem stock traded up $0.01 during trading on Friday, hitting $0.36. 4,333,952 shares of the stock traded hands, compared to its average volume of 5,503,773. The company has a debt-to-equity ratio of 1.41, a quick ratio of 1.51 and a current ratio of 1.10. The company has a fifty day moving average price of $0.45 and a two-hundred day moving average price of $0.91. The stock has a market cap of $58.92 million, a P/E ratio of -0.07 and a beta of 1.65. Stem has a twelve month low of $0.30 and a twelve month high of $4.30.

Stem (NYSE:STEMGet Free Report) last issued its quarterly earnings results on Tuesday, August 6th. The company reported ($0.22) EPS for the quarter, beating the consensus estimate of ($0.23) by $0.01. The firm had revenue of $34.00 million during the quarter, compared to analysts’ expectations of $64.06 million. Stem had a negative return on equity of 275.79% and a negative net margin of 328.11%. The business’s quarterly revenue was down 63.4% compared to the same quarter last year. During the same period in the prior year, the firm posted ($0.56) earnings per share. Equities research analysts predict that Stem will post -0.52 EPS for the current fiscal year.

Institutional Investors Weigh In On Stem

A number of institutional investors and hedge funds have recently bought and sold shares of STEM. Mirae Asset Global Investments Co. Ltd. increased its position in shares of Stem by 90.3% in the 1st quarter. Mirae Asset Global Investments Co. Ltd. now owns 222,575 shares of the company’s stock valued at $487,000 after acquiring an additional 105,643 shares during the period. GSA Capital Partners LLP purchased a new position in Stem in the 1st quarter valued at approximately $513,000. Healthcare of Ontario Pension Plan Trust Fund lifted its position in shares of Stem by 15.7% during the 1st quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 167,298 shares of the company’s stock worth $366,000 after purchasing an additional 22,703 shares during the last quarter. Price T Rowe Associates Inc. MD increased its stake in Stem by 45.9% in the first quarter. Price T Rowe Associates Inc. MD now owns 158,102 shares of the company’s stock valued at $347,000 after purchasing an additional 49,713 shares during the period. Finally, Levin Capital Strategies L.P. boosted its holdings in Stem by 204.6% during the first quarter. Levin Capital Strategies L.P. now owns 390,000 shares of the company’s stock worth $854,000 after buying an additional 261,980 shares in the last quarter. 61.63% of the stock is owned by institutional investors.

About Stem

(Get Free Report)

Stem, Inc operates as a digitally connected, intelligent, and renewable energy storage network provider worldwide. The company offers energy storage hardware sourced from original equipment manufacturers (OEMs); edge hardware to aid in the collection of site data and real-time operation and control of the site and other optional equipment; and Athena, a software platform, which offers battery hardware and software-enabled services to operate the energy storage systems.

Further Reading

Analyst Recommendations for Stem (NYSE:STEM)

Receive News & Ratings for Stem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stem and related companies with MarketBeat.com's FREE daily email newsletter.